Patheon shares deflate on flat forecast

Article Abstract:

Patheon Inc. saw its share value decline by 18% after the company forecasted flat profits for the fiscal year ending October 31, 2001. Patheon shares fell to 10.95 Canadian dollars per share after dropping previously to 10.85 Canadian dollars per share.

Prices and rates, Securities prices, Patheon Inc.

---

Partners' dispute hits Angiotech shares

Article Abstract:

Angiotech Pharmaceuticals Inc. saw its share value drop by an additional 11% on September 13, 2001. The company is caught amidst a drug-coated medical device dispute between its two research partners

Angiotech Pharmaceuticals Inc.

---

Oncolytics Biotech rises on cancer virus news

Article Abstract:

With the announcement of promising news concerning its cancer treatment, Oncolytics Biotech Inc.'s shares rise five percent.

Research and Testing Services, Anticancer Drugs, Antineoplastic agents, Oncolytics Biotech Inc.

Similar abstracts:

• Abstracts: Blockbuster to settle late-fee lawsuit. Under fire, bood giants switch to healthier fare. Vidal Sassoon takes on a hairy fight against P&G
• Abstracts: Miners lay out welcome mat for bats. Mining tycoon Telfer digs deep with U of O donation. Mining firm reveals convictions
• Abstracts: Lumber prices surge on fire woes. U.S. delivers on its lumber threat. Beetles worsen B.C. lumber woes
• Abstracts: Cash concerns: a fund you can really trust. Capital idea
• Abstracts: Arctic reorganization may hinge on debt payments. Former Arakis Energy chief fined $1.2-million. Lundins go where others fear to tread

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.